We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WLTH:NASDAQWealthfront Corporation Analysis

Data as of 2026-08-13 - not real-time

$9.33

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Wealthfront Corporation is neutral at $9.33, with no clear ordering between short and long averages. Over a rolling month the price has gained 4.4%. Momentum indicators put RSI at 47.8 (neutral) with MACD reading bullish. Recent trading has carved out support near $8.83 and resistance around $9.87.
Valuation screens as undervalued: a P/E of 12.0 sits below the sector average of 36.7. Sell-side targets cluster 31.3% above the current quote. Revenue is growing at 7.1% on a -14.9% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 40.2%, a beta of 1.69 and a maximum drawdown of 48.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.

Top Market Events

Wealthfront’s mortgage offering is now live in California, Colorado and Texas, with expansions to Florida, Illinois,...Investing.com -- Wealthfront Corporation Nasdaq: WLTH is extending its mortgage business into California, its largest...Benzinga.com7yWealthfront Stock Short Interest Report NASDAQ:WLTH BenzingaShort interest in Wealthfront Corp...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 9.96
  • MACD momentum is positive
  • 30-day volatility of 40.2%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 12.0 versus sector average of 36.7
  • Trading below the 200-day average of 9.96
  • Analyst targets imply +31.3% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 12.0 versus sector average of 36.7
  • Negative profit margin of -14.9%
  • Analyst targets imply +31.3% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth7.10%
Profit Margin-14.88%
P/E Ratio12.0
ROE-12.88%
Debt/Equity1.53
P/B Ratio2.3
Op. Cash Flow$136.4M
Industry P/E36.7

Technical Analysis

TrendNeutral
RSI47.8
Support$8.83
Resistance$9.87
MA 20$9.40
MA 50$9.28
MA 200$9.96
MACDBullish
VolumeStable
Fear & Greed Index95.16

Valuation

Fair Value$13.85
Target Price$12.25
Upside/Downside31.30%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.69
Volatility40.15%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.